Photocurable bioinks for the fabrication of bone scaffold in bone tissue engineering
BME Horizon · 2024
DOI: 10.70401/bmeh.2026.0015 ↗Kurz gefasst
Fachartikel in der Zeitschrift BME Horizon, 2024. Verfasst von Lei Nie und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Bone tissue engineering (BTE) is pivotal for addressing bone defects. It integrates biomaterials, cells, and bioactive factors to mimic the natural bone microenvironment, thereby promoting bone regeneration and repair. In this system, scaffolds provide physical support and nutrient transport for cells. Three-dimensional (3D) printing revolutionizes BTE by fabricating customized scaffolds tailored to individual patients. As the cornerstone of 3D bioprinting, bioinks must meet strict biocompatibility and printability requirements to drive BTE advancement. In this review, we first explore the principles, advantages, and limitations of various bioprinting techniques. Furthermore, we also summarized recent breakthroughs and merits of three key photo-crosslinking reactions, including photoinitiated free radical crosslinking, photoclick crosslinking, and photo-conjugation crosslinking. Moreover, this review focused on the properties of natural polymers, synthetic polymers, and calcium phosphate-based inorganic materials in bioink formulation, as well as their BTE applications. Finally, a concise outlook on the future advancement of photocurable bioinks was provided.
Zitieren
APA
Nie, L., Liang, Y., Li, J., & Ding, P. (2024). Photocurable bioinks for the fabrication of bone scaffold in bone tissue engineering. BME Horizon. https://doi.org/10.70401/bmeh.2026.0015
Vancouver
Nie L, Liang Y, Li J, Ding P. Photocurable bioinks for the fabrication of bone scaffold in bone tissue engineering. BME Horizon. 2024. doi:10.70401/bmeh.2026.0015
BibTeX
@article{Nie2024,
author = {Nie, Lei and Liang, Yingying and Li, Jingyi and Ding, Peng},
title = {Photocurable bioinks for the fabrication of bone scaffold in bone tissue engineering},
journal = {BME Horizon},
year = {2024},
doi = {10.70401/bmeh.2026.0015}
}
EUVIMED